NO20030483L - Assosiasjoner av dalfopristin/quinupristin med cefpirom - Google Patents

Assosiasjoner av dalfopristin/quinupristin med cefpirom

Info

Publication number: NO20030483L
Authority: NO; Norway
Prior art keywords: cefpiroma; dalfopristine; quinupristine; associations
Prior art date: 2000-08-03

Application number

NO20030483A

Other languages

English (en)

Norwegian (no)

Other versions

NO20030483D0 (no

Inventor

Celine Feger

Philippe Moreillon

Jacques Vouillamoz

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2003-01-30

Publication date

2003-01-30

2003-01-30 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-01-30 Publication of NO20030483D0 publication Critical patent/NO20030483D0/no

2003-01-30 Publication of NO20030483L publication Critical patent/NO20030483L/no

Links

DKOQGJHPHLTOJR-WHRDSVKCSA-N cefpirome Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DKOQGJHPHLTOJR-WHRDSVKCSA-N 0.000 title 1
SUYRLXYYZQTJHF-VMBLUXKRSA-N dalfopristin Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1 SUYRLXYYZQTJHF-VMBLUXKRSA-N 0.000 title 1
WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Thyristors (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

NO20030483A 2000-08-03 2003-01-30 Assosiasjoner av dalfopristin/quinupristin med cefpirom NO20030483L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0010245A FR2812549B1 (fr)	2000-08-03	2000-08-03	Associations dalfopristine/quinupristine avec le cefpirome
PCT/FR2001/002520 WO2002011751A2 (fr)	2000-08-03	2001-08-02	Associations dalfopristine/quinupristine avec le cefpirome

Publications (2)

Publication Number	Publication Date
NO20030483D0 NO20030483D0 (no)	2003-01-30
NO20030483L true NO20030483L (no)	2003-01-30

Family

ID=8853264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030483A NO20030483L (no)	2000-08-03	2003-01-30	Assosiasjoner av dalfopristin/quinupristin med cefpirom

Country Status (28)

Country	Link
US (2)	US7005416B2 (cs)
EP (1)	EP1313500B1 (cs)
JP (1)	JP2004505926A (cs)
KR (1)	KR100808715B1 (cs)
CN (1)	CN1256982C (cs)
AR (1)	AR033992A1 (cs)
AT (1)	ATE279204T1 (cs)
AU (2)	AU2001284095B2 (cs)
BR (1)	BR0112897A (cs)
CA (1)	CA2418023A1 (cs)
CZ (1)	CZ2003290A3 (cs)
DE (1)	DE60106463T2 (cs)
DK (1)	DK1313500T3 (cs)
EA (1)	EA007713B1 (cs)
ES (1)	ES2230358T3 (cs)
FR (1)	FR2812549B1 (cs)
HU (1)	HU227455B1 (cs)
IL (1)	IL154237A0 (cs)
MX (1)	MXPA03000959A (cs)
NO (1)	NO20030483L (cs)
NZ (1)	NZ523982A (cs)
PE (1)	PE20020264A1 (cs)
PL (1)	PL204278B1 (cs)
PT (1)	PT1313500E (cs)
SK (1)	SK1202003A3 (cs)
TN (1)	TNSN01116A1 (cs)
WO (1)	WO2002011751A2 (cs)
ZA (1)	ZA200300903B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN107420042B (zh) *	2017-09-25	2023-03-31	中国地质大学（武汉）	一种基于六自由度并联机构的海底钻机自动调平系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0867676A (ja) *	1994-03-30	1996-03-12	Eisai Kagaku Kk	保護アミノチアゾリル酢酸誘導体
US5464616A (en) *	1994-08-04	1995-11-07	Synphar Laboratories, Ind.	6β-substituted penicillanic acids as beta-lactamase inhibitors
US5686441A (en) *	1995-08-04	1997-11-11	Syphar Laboratories, Inc.	Penam sulfones as β-lactamase inhibitors
FR2755857B1 (fr) *	1996-11-19	1998-12-24	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
US6187746B1 (en) *	1997-12-16	2001-02-13	Rhone-Poulenc Rorer S.A.	Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US6465428B1 (en) *	1999-08-27	2002-10-15	Aventis Pharma S.A.	Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime

2000
- 2000-08-03 FR FR0010245A patent/FR2812549B1/fr not_active Expired - Fee Related
2001
- 2001-07-26 PE PE2001000759A patent/PE20020264A1/es not_active Application Discontinuation
- 2001-08-01 AR ARP010103684A patent/AR033992A1/es unknown
- 2001-08-01 TN TNTNSN01116A patent/TNSN01116A1/fr unknown
- 2001-08-02 CN CNB018148573A patent/CN1256982C/zh not_active Expired - Fee Related
- 2001-08-02 PT PT01963045T patent/PT1313500E/pt unknown
- 2001-08-02 KR KR1020037001575A patent/KR100808715B1/ko not_active Expired - Lifetime
- 2001-08-02 SK SK120-2003A patent/SK1202003A3/sk unknown
- 2001-08-02 AU AU2001284095A patent/AU2001284095B2/en not_active Ceased
- 2001-08-02 DK DK01963045T patent/DK1313500T3/da active
- 2001-08-02 PL PL365075A patent/PL204278B1/pl not_active IP Right Cessation
- 2001-08-02 MX MXPA03000959A patent/MXPA03000959A/es unknown
- 2001-08-02 NZ NZ523982A patent/NZ523982A/en not_active IP Right Cessation
- 2001-08-02 IL IL15423701A patent/IL154237A0/xx unknown
- 2001-08-02 AU AU8409501A patent/AU8409501A/xx active Pending
- 2001-08-02 EA EA200300214A patent/EA007713B1/ru unknown
- 2001-08-02 BR BR0112897-3A patent/BR0112897A/pt not_active IP Right Cessation
- 2001-08-02 CA CA002418023A patent/CA2418023A1/fr not_active Abandoned
- 2001-08-02 HU HU0300682A patent/HU227455B1/hu not_active IP Right Cessation
- 2001-08-02 CZ CZ2003290A patent/CZ2003290A3/cs unknown
- 2001-08-02 DE DE60106463T patent/DE60106463T2/de not_active Expired - Lifetime
- 2001-08-02 AT AT01963045T patent/ATE279204T1/de not_active IP Right Cessation
- 2001-08-02 ES ES01963045T patent/ES2230358T3/es not_active Expired - Lifetime
- 2001-08-02 WO PCT/FR2001/002520 patent/WO2002011751A2/fr not_active Ceased
- 2001-08-02 EP EP01963045A patent/EP1313500B1/fr not_active Expired - Lifetime
- 2001-08-02 JP JP2002517086A patent/JP2004505926A/ja active Pending
- 2001-08-03 US US09/920,810 patent/US7005416B2/en not_active Expired - Lifetime
2003
- 2003-01-30 NO NO20030483A patent/NO20030483L/no not_active Application Discontinuation
- 2003-01-31 ZA ZA200300903A patent/ZA200300903B/en unknown
2006
- 2006-01-04 US US11/325,919 patent/US20060122103A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1313500E (pt)	2005-02-28
PL204278B1 (pl)	2009-12-31
ZA200300903B (en)	2003-11-10
US20060122103A1 (en)	2006-06-08
EA200300214A1 (ru)	2003-06-26
AU8409501A (en)	2002-02-18
EA007713B1 (ru)	2006-12-29
CN1256982C (zh)	2006-05-24
EP1313500B1 (fr)	2004-10-13
FR2812549B1 (fr)	2003-03-21
US20020037890A1 (en)	2002-03-28
AR033992A1 (es)	2004-01-21
NO20030483D0 (no)	2003-01-30
IL154237A0 (en)	2003-07-31
HUP0300682A2 (hu)	2003-08-28
KR100808715B1 (ko)	2008-02-29
US7005416B2 (en)	2006-02-28
PE20020264A1 (es)	2002-05-20
HU227455B1 (en)	2011-06-28
NZ523982A (en)	2004-10-29
AU2001284095B2 (en)	2007-04-05
SK1202003A3 (en)	2003-07-01
HK1058305A1 (en)	2004-05-14
CN1449290A (zh)	2003-10-15
JP2004505926A (ja)	2004-02-26
ES2230358T3 (es)	2005-05-01
DE60106463D1 (de)	2004-11-18
EP1313500A2 (fr)	2003-05-28
PL365075A1 (en)	2004-12-27
TNSN01116A1 (fr)	2005-11-10
DK1313500T3 (da)	2005-02-14
FR2812549A1 (fr)	2002-02-08
BR0112897A (pt)	2003-06-10
KR20030022351A (ko)	2003-03-15
WO2002011751A2 (fr)	2002-02-14
WO2002011751A3 (fr)	2002-06-13
CZ2003290A3 (cs)	2003-05-14
HUP0300682A3 (en)	2004-09-28
MXPA03000959A (es)	2003-06-09
CA2418023A1 (fr)	2002-02-14
DE60106463T2 (de)	2005-10-13
ATE279204T1 (de)	2004-10-15

Legal Events

Date	Code	Title	Description
2008-03-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20024627D0 (no)	2002-09-27	Inhibering av cyklooksygenase-1-aktivitet
CY2013011I2 (el)	2015-08-05	Μεθοδος χορηγησης διφωσφονικων
ID30590A (id)	2002-01-03	Celana sekali pakai jenis-celana pendek
DE60101991D1 (de)	2004-03-18	Gleichstrom- zu Gleichstromumwandler
ATE296619T1 (de)	2005-06-15	Feste orale dosierungsform von simethicon
DE60024988D1 (de)	2006-01-26	Herstellung von therapeutischem mikroschaum
DE60132108D1 (de)	2008-02-07	Gefriergetrocknetes pantoprazol-präparat und pantoprazol-injektion
FI19992600L (fi)	2001-06-03	Audiomuunnin
NO20013965L (no)	2001-10-17	Aktivering av nedihullsanordninger
ID30187A (id)	2001-11-15	Dongkrak jenis pantagraf
NO20014950L (no)	2001-12-13	Nye behandlingsmetoder
NO20024486L (no)	2002-09-19	Forbedret behandling av neovaskularisering
NO20020742D0 (no)	2002-02-14	Innskrenkning av innretninger for å lyddempe operasjoner
NO20041968L (no)	2004-05-11	Anvendelse av cystationin
NO20025964L (no)	2003-02-14	Ny interferon for behandling av multippel sklerose
EE200100623A (et)	2003-02-17	Melatoniini terapeutiline kasutamine
NO20032156L (no)	2003-05-13	Behandling av angstforstyrrelser
DE50115341D1 (de)	2010-03-25	Spannungswandler
NO20030483L (no)	2003-01-30	Assosiasjoner av dalfopristin/quinupristin med cefpirom
DK1351697T3 (da)	2014-01-20	Lægemiddel til fremme af regenerationen af væv
DE60007360D1 (de)	2004-01-29	Amorphe modifikation von torasemid
NO20013795D0 (no)	2001-08-02	Regulering av anestesi
ID30381A (id)	2001-11-29	Penggunaan arilalkanoilpiridazina
NO20033163D0 (no)	2003-07-10	Ny anvendelse av iloperidon
NO20023243D0 (no)	2002-07-04	Ny terapeutisk anvendelse av enoxaparin